FDA is currently reviewing cell therapy products like Breyanzi®, seeking approval for CAR-T cell therapies, but noted insufficient information to establish a link.
1 report, 1 independent
Updated Sep 4
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA is currently reviewing cell therapy products like Breyanzi®, seeking approval for CAR-T cell therapies, but noted insufficient information to establish a link.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Juno Therapeutics
biopharmaceutical company
Nothing else this week.
Related events
- Baylor College of Medicine researchers participated in a study on CAR T-cell therapy, co-authored by Andras Heczey.
- Experimental therapies require approval from the FDA.
- Solid Biosciences received FDA approval for a gene therapy trial on July 9, 2025.
- FDA and Pfizer are seeking regulatory approval for their products.
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.